Fibroblast activation protein (FAP) as a novel metabolic target
Objective: Fibroblast activation protein (FAP) is a serine protease belonging to a S9B prolyl oligopeptidase subfamily. This enzyme has been implicated in cancer development and recently reported to regulate degradation of FGF21, a potent metabolic hormone. Using a known FAP inhibitor, talabostat (T...
Main Authors: | Miguel Angel Sánchez-Garrido, Kirk M. Habegger, Christoffer Clemmensen, Cassie Holleman, Timo D. Müller, Diego Perez-Tilve, Pengyun Li, Archita S. Agrawal, Brian Finan, Daniel J. Drucker, Matthias H. Tschöp, Richard D. DiMarchi, Alexei Kharitonenkov |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-10-01
|
Series: | Molecular Metabolism |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877816300965 |
Similar Items
-
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
by: Archita Agrawal, et al.
Published: (2018-07-01) -
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
by: Sigrid Jall, et al.
Published: (2017-05-01) -
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
by: Piotr A. Mroz, et al.
Published: (2019-02-01) -
Glucagon receptor signaling regulates weight loss via central KLB receptor complexes
by: Shelly R. Nason, et al.
Published: (2021-02-01) -
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
by: Yuli Lin, et al.
Published: (2019-12-01)